期刊文献+

恶性肿瘤患者发生贫血的危险因素分析 被引量:11

An Analysis on Risk Factors of Anemia in Patients with Malignancy
原文传递
导出
摘要 [目的]探讨恶性肿瘤患者贫血的发生情况及其相关危险因素。[方法]回顾性分析我院综合科2010年1月至12月收治的986例恶性肿瘤患者,进行单因素和多因素Logistic回归分析。[结果]所有患者中,男性573例(58.2%),女性413例(41.8%),死亡124例,贫血669例,贫血发生率为67.8%。Ⅰ级295例(44.1%),Ⅱ级218例(32.6%),Ⅲ级87例(13.0%),Ⅳ级69例(10.3%)。胃肠道肿瘤贫血发生率最高为77.5%。单因素分析显示,年龄、肿瘤分期、抗肿瘤治疗、肿瘤类型、合并出血与恶性肿瘤贫血的发生有关,具有统计学意义(P<0.05)。多因素Logistic回归分析显示,合并出血、临床分期、抗肿瘤治疗与贫血发生密切相关。[结论]恶性肿瘤患者贫血发生率较高;肿瘤分期、合并出血和抗肿瘤治疗是恶性肿瘤贫血发生的危险因素。 [Purpose] To explore the occurrence of anemia in patients with malignancy and the related risk factors. [Methods] A retrospective analysis was performed in 986 patients with malignancy from January to December (2010) by single factor analysis and multivarite logistic analysis. [Results] Among all the cases,there were 573(58.2%) in male,413(41.8%) in female and 124 patients died of cancer. Anemia occurred in 669 cases account for 67.8% of all the cases with malignancy. Based on anemia grading,295 cases(44.1%) was grade Ⅰ,218(32.6%) grade Ⅱ,87(13.0%) grade Ⅲ,69 (10.3%) grade Ⅳ . Gastrointestinal cancer was the highest occurence of anemia with 77.5% .Univariant analysis demonstrated that anemia was correlated to age,grade,anti-neoplastic therapy,tumor type and combined bleeding,with statistic significance (P0.05). Multivarite logistic analysis showed that bleeding, and anti-neoplastic therapy were significantly correlated to anemia. [Conclusion] Patients with malignancy have a high occurence of anemia. Tumor stage,bleeding and anti-neoplastic therapy are the risk factors of anemia in patients with malignancy.
作者 于雷
出处 《中国肿瘤》 CAS 2013年第5期403-405,共3页 China Cancer
关键词 肿瘤 癌性贫血 危险因素 neoplasm cancer-related anemia risk factor
  • 相关文献

参考文献2

二级参考文献62

共引文献95

同被引文献129

  • 1张怡梅,高冬梅,苏同义,刘建坤,陈连刚.升血调元颗粒治疗肿瘤放化疗后相关性贫血临床观察[J].环球中医药,2013,6(S2):53-54. 被引量:2
  • 2王卫东,孙苏平,王向东.血红蛋白浓度对非小细胞肺癌放疗疗效的影响[J].实用肿瘤学杂志,2004,18(4):287-289. 被引量:1
  • 3黄晓东,易俊林,高黎,徐国镇,李素艳,蔡伟明,罗京伟.放疗前贫血对鼻咽癌预后的影响[J].中华放射肿瘤学杂志,2006,15(2):73-76. 被引量:30
  • 4周立新,吴伟新,李明,俞伟君.重组人红细胞生成素纠正胃癌患者术前贫血的临床观察[J].药学服务与研究,2006,6(5):355-357. 被引量:2
  • 5李博,石远凯.贫血对肿瘤患者的影响及治疗[J].癌症进展,2007,5(3):269-275. 被引量:25
  • 6Barre- Lee PJ, Bailey NP, OBrien ME, et al. Large -scale UK audit of blood transfusion requirements and anaemia in patients receiving eyto- toxic ehemo - therapy[J]. Br J Caneer, 2000,82( 1 ) :93 -97.
  • 7Oster HS, Prutehi - Sagiv S, Halutz O, et al. Erythropoietin treatment is associated with an augmented immune response to the influenza vac- cine in hematologic patients [ J ]. Exp Hematol, 2013,41 ( 2 ) : 167 - 171.
  • 8Mercadante S, Gebbia V, Marrazzo A, et al. Anaemia in cancer: pathophysiology and treatment [ J ]. Cancer Treat Rev, 2000,26 (4) : 303 -311.
  • 9Yong Yu,Xun Xu,Ziyan Du,Minhua Shi.Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials[J]. Cancer Chemotherapy and Pharmacology . 2012 (5)
  • 10Yukiko Kishida,Takashi Hirose,Takao Shirai,Tomohide Sugiyama,Soujiro Kusumoto,Toshimitsu Yamaoka,Kentaro Okuda,Mitsuru Adachi,Akihiro Nakamura.Myelosuppression induced by concurrent chemoradiotherapy as a prognosticfactor for patients with locally advanced non-small cell lung cancer[J]. Oncology Letters . 2011 (5)

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部